Skip to main content

HITACHI REVIEW

Hitachi

  • September 2007

AUTHORS

Kenji Otoshi Pharma and Biotech Systems Dept., Industrial & Logistics Systems Div., Total Solutions Div., Hitachi, Ltd.
Hiroshi Tomita Traceability Solutions Dept., RFID Technology/Traceability & Supply Chain Innovation Project, Information & Telecommunication Systems, Hitachi, Ltd.
Toshiyuki Kaneko Business Development Dept., Research & Development Div., Information & Control Systems Div., Maxell Seiki, Ltd.

OVERVIEW

In recent years, there has been considerably progress in leveraging RFID in many different areas. The pharmaceutical industry in particular is looking to RFID as a reliable way to detect and deter counterfeit drugs and medicines. As a fundamental solution to the problem of bogus drugs, the FDA (Food and Drug Administration) of the U.S., the country accounting for close to 50% of drug and medicine sales worldwide, recommends RFID tagging of prescription drugs, and some manufacturers have begun to tag their pharmaceuticals at the individual package level. Adoption of RFID is also expected to greatly reduce human errors when dispensing drugs at hospitals and pharmacies, and a number of pilot studies and trials are now in progress. Hitachi, Ltd. has proposed a number of innovative RFID solutions based on the company's achievements developing systems for the medical and pharmaceutical industries, RFID-related research and development, and substantial expertise gained through participation in government and ministry sponsored IC tag pilot studies and trials.

KEYWORDS

RFID Pharmaceutical, RFID Medical, μ-Chip, Hitachi RFID, Coil-on-Chip

Download Adobe Reader
Adobe® Reader® of Adobe Systems Incorporated (Adobe Systems) is required to view PDF documents.